Biogen Inc (NASDAQ:BIIB)
| 278.05 Delayed Data As of Mar 31 |  +2.92 / +1.06%Today’s Change | 187.16 Today|||52-Week Range 311.88 | +0.41% Year-to-Date |
Latest BIIB News | Press Releases
Today’s Trading
| Previous close | 275.13 |
| Today’s open | 275.98 |
| Day’s range | 275.51 - 278.91 |
| Volume | 55,389 |
| Average volume (3 months) | 1,060,368 |
| Market cap | $40.2B |
Data as of 4:00pm ET, 03/31/2023
Growth & Valuation
| Earnings growth (last year) | +100.92% |
| Earnings growth (this year) | -12.12% |
| Earnings growth (next 5 years) | +4.28% |
| Revenue growth (last year) | -9.32% |
| P/E ratio | 13.3 |
| Price/Sales | 4.29 |
| Price/Book | 2.99 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | +7.32 | +3.25% |
| MRNAModerna Inc | +6.15 | +4.17% |
| ---- | ||
| BMRNBiomarin Pharmaceuti... | +1.99 | +2.09% |
Data as of 4:00pm ET, 03/31/2023
Financials
| Next reporting date | April 26, 2023 |
| EPS forecast (this quarter) | $3.39 |
| Annual revenue (last year) | $9.4B |
| Annual profit (last year) | $3.0B |
| Net profit margin | 32.30% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
